SYN (SYN) Stock Price, News & Analysis
Company Description
SYN (NYSE: SYN) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $16.2M.
This page collects what Stock Titan holds for SYN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latest News
SYN has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 5 with negative movement. Key topics include clinical trial, earnings, conferences, earnings date, private placement. View all SYN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
SYN Company Profile & Sector Positioning
SYN (SYN) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NYSE.
Investors comparing SYN often look at related companies in the same sector, including Edesa Biotech Inc (EDSA), Cellectar Biosciences Inc (CLRB), Tharimmune Inc (THAR), MetaVia Inc (MTVA), and Longeveron Inc (LGVN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SYN's relative position within its industry.